Mark Wagner to Male
This is a "connection" page, showing publications Mark Wagner has written about Male.
Connection Strength
0.117
-
Therapeutic effect of increased openness: Investigating mechanism of action in MDMA-assisted psychotherapy. J Psychopharmacol. 2017 08; 31(8):967-974.
Score: 0.032
-
Preliminary examination of progression of Alzheimer's disease in a rural Southern African American cohort. Arch Clin Neuropsychol. 2007 Mar; 22(3):405-14.
Score: 0.015
-
Use of the Personality Assessment Inventory as an efficacious and cost-effective diagnostic tool for nonepileptic seizures. Epilepsy Behav. 2005 Sep; 7(2):301-4.
Score: 0.014
-
The Test of Memory Malingering (TOMM): normative data from cognitively intact, cognitively impaired, and elderly patients with dementia. Arch Clin Neuropsychol. 2004 Apr; 19(3):455-64.
Score: 0.013
-
Diagnostic challenges of using CSF assay of tau and beta-amyloid(42) in atypical degenerative dementias of the Alzheimer type. Arch Clin Neuropsychol. 2003 Dec; 18(8):893-903.
Score: 0.012
-
Utility of a clinically derived abbreviated form of the WAIS-III. Arch Clin Neuropsychol. 2003 Dec; 18(8):917-27.
Score: 0.012
-
APOE genotype in the diagnosis of Alzheimer's disease in patients with cognitive impairment. Am J Alzheimers Dis Other Demen. 2012 Aug; 27(5):315-20.
Score: 0.006
-
The impact of clinical and demographic variables on cognitive performance in methamphetamine-dependent individuals in rural South Carolina. Am J Addict. 2011 Sep-Oct; 20(5):447-55.
Score: 0.005
-
Establishment of a predominantly African-American cohort for the study of Alzheimer's disease: the South Carolina Alzheimer's disease clinical core. Dement Geriatr Cogn Disord. 2009; 27(4):329-36.
Score: 0.004
-
Transient Kluver-Bucy syndrome following complex partial status epilepticus. Epilepsy Behav. 2003 Jun; 4(3):348-51.
Score: 0.003